GlassScriptPhysician profile
Cindy D Griffith
NPI 1366709099
$5,149.42
in general payments reported to CMS, 2019-2025
32 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,629 · 2022: $1,637 · 2023: $1,228 · 2024: $387 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,111.12 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $754.33 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $546.40 | 2021-2023 | Xarelto |
| Amgen INC. | $354.41 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $318.58 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $210.74 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $194.99 | 2021-2023 | Verquvo, Belsomra |
| Actelion Pharmaceuticals US, INC. | $164.88 | 2021-2022 | |
| Amarin Pharma, INC. | $159.44 | 2021 | |
| Esperion Therapeutics, INC. | $154.33 | 2021-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $142.79 | 2021-2025 | Wainua, Farxiga |
| Boston Scientific Corporation | $139.91 | 2021-2025 | Watchman Access System |
| Janssen Biotech, INC. | $128.66 | 2021-2022 | |
| Edwards Lifesciences Corporation | $92.11 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Daiichi Sankyo INC. | $84.04 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $76.20 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.68 | 2021-2022 | |
| Abbott Laboratories | $72.02 | 2021-2024 | Cardiomems |
| Abiomed | $50.03 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $44.54 | 2022-2023 | Eliquis |
| Scpharmaceuticals INC. | $43.96 | 2023 | |
| Kestra Medical Technology Services, INC. | $37.09 | 2024-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $35.54 | 2024 | Optimizer |
| Vital Connect, INC | $31.17 | 2023-2025 | Vitalpatch Rtm |
| United Therapeutics Corporation | $24.34 | 2022 | |
| Irhythm Technologies, INC. | $19.39 | 2023 | Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $17.42 | 2023 | Inpefa |
| Heartflow, INC. | $16.30 | 2025 | |
| Elutia, INC. | $13.89 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.70 | 2021 | |
| Amryt Pharma Holdings LTD | $12.64 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.